TY - JOUR
T1 - Perioperative mortality in Colombia
T2 - Perspectives of the fourth indicator in The Lancet Commission on Global Surgery – Colombian Surgical Outcomes Study (ColSOS) – a protocol for a multicentre prospective cohort study
AU - Pérez-Rivera, Carlos J.
AU - Lozano-Suárez, Nicolás
AU - Velandia-Sánchez, Alejandro
AU - Polanía-Sandoval, Camilo A.
AU - García-Méndez, Juan P.
AU - Idarraga-Ayala, Sharon V.
AU - Corso-Ramírez, Julián M.
AU - Conde-Monroy, Danny
AU - Cruz-Reyes, Danna L.
AU - Durán-Torres, Carlos F.
AU - Barrera-Carvajal, Juan G.
AU - Rojas-Serrano, Luisa Fernanda
AU - Garcia-Zambrano, Laura Alejandra
AU - Agudelo-Mendoza, Silvia Valentina
AU - Briceno-Ayala, Leonardo
AU - Cabrera-Rivera, Paulo A.
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2022/11/30
Y1 - 2022/11/30
N2 - Introduction: Death following surgical procedures is a global health problem, accounting for 4.2 million deaths annually within the first 30 postoperative days. The fourth indicator of The Lancet Commission on Global Surgery is essential as it seeks to standardise postoperative mortality. Consequently, it helps identify the strengths and weaknesses of each country's healthcare system. Accurate information on this indicator is not available in Colombia, limiting the possibility of interventions applied to our population. We aim to describe the in-hospital perioperative mortality of the surgical procedures performed in Colombia. The data obtained will help formulate public policies, improving the quality of the surgical departments. Methods and analysis An observational, analytical, multicentre prospective cohort study will be conducted throughout Colombia. Patients over 18 years of age who have undergone a surgical procedure, excluding radiological/endoscopic procedures, will be included. A sample size of 1353 patients has been projected to achieve significance in our primary objective; however, convenience sampling will be used, as we aim to include all possible patients. Data collection will be carried out prospectively for 1 week. Follow-up will continue until hospital discharge, death or a maximum of 30 inpatient days. The primary outcome is perioperative mortality. A descriptive analysis of the data will be performed, along with a case mix analysis of mortality by procedure-related, patient-related and hospital-related conditions Ethics and dissemination The Fundación Cardioinfantil-Instituto de Cardiología Ethics Committee approved this study (No. 41-2021). The results are planned to be disseminated in three scenarios: the submission of an article for publication in a high-impact scientific journal and presentations at the Colombian Surgical Forum and the Congress of the American College of Surgeons. Trial registration number NCT05147623.
AB - Introduction: Death following surgical procedures is a global health problem, accounting for 4.2 million deaths annually within the first 30 postoperative days. The fourth indicator of The Lancet Commission on Global Surgery is essential as it seeks to standardise postoperative mortality. Consequently, it helps identify the strengths and weaknesses of each country's healthcare system. Accurate information on this indicator is not available in Colombia, limiting the possibility of interventions applied to our population. We aim to describe the in-hospital perioperative mortality of the surgical procedures performed in Colombia. The data obtained will help formulate public policies, improving the quality of the surgical departments. Methods and analysis An observational, analytical, multicentre prospective cohort study will be conducted throughout Colombia. Patients over 18 years of age who have undergone a surgical procedure, excluding radiological/endoscopic procedures, will be included. A sample size of 1353 patients has been projected to achieve significance in our primary objective; however, convenience sampling will be used, as we aim to include all possible patients. Data collection will be carried out prospectively for 1 week. Follow-up will continue until hospital discharge, death or a maximum of 30 inpatient days. The primary outcome is perioperative mortality. A descriptive analysis of the data will be performed, along with a case mix analysis of mortality by procedure-related, patient-related and hospital-related conditions Ethics and dissemination The Fundación Cardioinfantil-Instituto de Cardiología Ethics Committee approved this study (No. 41-2021). The results are planned to be disseminated in three scenarios: the submission of an article for publication in a high-impact scientific journal and presentations at the Colombian Surgical Forum and the Congress of the American College of Surgeons. Trial registration number NCT05147623.
UR - http://www.scopus.com/inward/record.url?scp=85143093596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85143093596&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2022-063182
DO - 10.1136/bmjopen-2022-063182
M3 - Research Article
C2 - 36450427
AN - SCOPUS:85143093596
SN - 2044-6055
VL - 12
SP - 1
EP - 10
JO - BMJ Open
JF - BMJ Open
IS - 11
M1 - e063182
ER -